Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Non-significant editorial updates were made: the page now explains that publications are automatically filled from PubMed and the revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-27T07:57:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Deleted the generic government funding operating status notice from the page. The study content, eligibility criteria, and contacts remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-19T22:16:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The Locations section now lists 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 73657', replacing 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 73657'.
    Difference
    0.0%
    Check dated 2025-11-12T18:50:25.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT04194944 LIBRETTO-431; core content such as the Study Title, design, interventions, primary and secondary outcomes, eligibility criteria, and Locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T10:10:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    No significant changes to core content or time-sensitive information detected; updates appear to be only date-related entries and deletions of some earlier dates.
    Difference
    0.2%
    Check dated 2025-10-22T06:30:21.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    - Location designation updated from Rhône-Alpes to Auvergne-Rhône-Alpes for Lyon with postal code unchanged. - Revision bumped from v3.1.0 to v3.2.0. - Added general government-operating-status notice (lower impact).
    Difference
    4%
    Check dated 2025-10-07T23:10:53.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.